CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1− mantle cell lymphomaDavid Martin‐García, Sı́lvia Beà, Alba Navarro et al.|Blood|2018Cited by 112
Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatmentHilma J. van der Horst, Tuna Mutis, A. Vera de Jonge et al.|Blood Cancer Journal|2021Cited by 95
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trialMartine E.D. Chamuleau, Marie José Kersten, Coreline N. Burggraaff et al.|Haematologica|2019Cited by 53
B-Cell and Classical Hodgkin Lymphomas Associated With ImmunodeficiencyDaphne de Jong, Yasodha Natkunam|American Journal of Clinical Pathology|2016Cited by 46
Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimensLiesbeth E.M. Oosten, Hendrik Veelken, Martine E.D. Chamuleau et al.|Annals of Hematology|2017Cited by 44